By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


XTL Biopharmaceuticals Ltd. 

Kiryat Weizmann, Science Park, Bldg 3
P.O. Box 370
Rehovot    76100  Israel
Phone: 972-8-932-4444 Fax: 972-8-930-4445


Company News
XTL Biopharma (XTLB) Announces $2.5 Million Registered Direct Offering 2/17/2017 6:32:21 AM
XTL Biopharma (XTLB) Expands Clinical Advisory Board To Support Phase II Study Of HCDR1 In Sjogren's Syndrome 2/13/2017 8:41:06 AM
XTL Biopharma (XTLB) Announces Ratio Change Of Its Depositary Receipt Program 1/27/2017 7:42:59 AM
XTL Biopharma (XTLB)' Preclinical Studies of hCDR1 Demonstrate Therapeutic Potental In the Treatment of Sj√∂gren's Syndrome 1/5/2017 6:49:12 AM
XTL Biopharma (XTLB) Reports Third Quarter 2016 Financial Results & Provides Clinical And Operational Update 12/6/2016 11:27:41 AM
XTL Biopharma (XTLB) Receives NASDAQ Notification Regarding Minimum Bid Requirements 11/10/2016 4:33:27 PM
XTL Biopharma (XTLB) Reports Second Quarter 2016 Financial Results & Provides Clinical And Operational Update 9/27/2016 10:41:47 AM
XTL Biopharma (XTLB) Announces The European Patent Office Has Issued A Patent For Its Lupus Drug hCDR1 9/7/2016 9:19:29 AM
XTL Biopharma (XTLB) To Present At Rodman & Renshaw Conference On September 12, 2016 9/6/2016 2:07:44 PM
XTL Biopharma (XTLB) Announces New Patent Filing In U.S. For Lupus Drug hCDR1 8/11/2016 7:28:17 AM